Investigating immune responses to a specific vaccine using advanced data analysis techniques
Omics, Bioinformatics, and Data Management Core
This study is looking at how a certain vaccine helps your immune system by checking how your immune cells react, and the findings could help create better vaccines for people like you.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon Health & Science University NIH-funded |
| Lab location | 1 site (Portland, United States) |
| Project ID | NIH-10895455 on NIH RePORTER |
What this research studies
This research focuses on understanding how a specific vaccine affects the immune response by analyzing gene expression signatures in immune cells. Using advanced bioinformatics and statistical methods, the project will examine various types of immune cells, including CD8+ T cells, in blood and tissues from pre-clinical studies. The goal is to identify specific immune responses that can prevent SIV replication, which is crucial for developing effective vaccines. Patients may benefit from insights gained through this research that could lead to improved vaccine strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are at risk for HIV and may benefit from enhanced vaccine strategies.
Not a fit: Patients who are not at risk for HIV or those who have already been effectively vaccinated against SIV may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective vaccines against SIV, potentially improving outcomes for patients at risk of HIV infection.
How similar studies have performed: Other research has shown success in using similar bioinformatics approaches to analyze immune responses, indicating potential for impactful findings in this area.
Where this research is happening
Portland, United States
- Oregon Health & Science University — Portland, United States (Active)
Researchers
- Principal investigator: Gale, Michael — Oregon Health & Science University
- Study coordinator: Gale, Michael
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.